Table 1.
Patients’ and control cohort characteristics
| n = 24 | Mean ± SD |
|---|---|
| Age (years) |
57.27 ± 16.33 |
| Male (%) |
65 |
| IPAH (%) |
60 |
| CTEPH (%) |
40 |
| BMI (kg/cm2) |
27,17 ± 6.45 |
| SvO2 (%) |
62.86 ± 7.92 |
| PAmean (mmHg) |
48.72 ± 18.69 |
| PVR (dyn*s*cm-5) |
638.18 ± 381.06 |
| Mean RAP (mmHg) |
10.82 ± 4.63 |
| Workload max (Watt) |
74.61 ± 21.07 |
| Peak VO2 (ml/kg/min) |
13.32 ± 3.3 |
| SysRRmax (mmHg) |
153.56 ± 32.42 |
| NT-proBNP (ng/L) |
363.39 ± 461.68 |
| 6-MWT (m) |
428.52 ± 118.96 |
| Ejection fraction (%) |
55.13 ± 4.34 |
| Diastolic LV-dysfunction (%) |
41.67 |
| History of CAD (%) |
12.5 |
| Creatinin (mg/dL) |
1.12 ± 0.83 |
|
Control cohort characteristics | |
|
n = 12 |
mean ± SD |
| Age (years) |
36.8 ± 10.7 |
| Male (%) |
58 |
| Workload max (Watt) |
244.58 ± 60.56 |
| Peak VO2 (ml/kg/min) |
38.73 ± 11.34 |
| NT-proBNP (ng/L) | 31.65 ± 42.49 |